E
OMIC

Ergoteles’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Ergoteles’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,860
Closed -$46.3K – 933
2023
Q2 		$46.3K Buy
1,860
+1,237
+199% +$36.2K ﹤0.01% 955
2023
Q1 		$22.6K Sell
623
-1,640
-72% -$100K ﹤0.01% 1156
2022
Q4 		$136K Buy
+2,263
New +$152K 0.01% 1168
2022
Q1 		– Sell
-1,678
Closed -$582K – 1712
2021
Q4 		$582K Buy
+1,678
New +$650K 0.02% 586

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles's OMIC Position: Q3 2023 in Review

Ergoteles sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2023, closing a stake of 1,860 shares — an estimated $46.3K sold.

Ergoteles first reported a position in OMIC in Q4 2021 and held it in 4 quarters. The position peaked at $582K in Q4 2021. 48 funds tracked by Wall St. Rank hold OMIC as of Q3 2023.

  • Ergoteles reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 1,860 Singular Genomics Systems, Inc. Common Stock shares in Q3 2023, an estimated $46.3K.
  • Ergoteles first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Ergoteles's Singular Genomics Systems, Inc. Common Stock position peaked at $582K in Q4 2021.
  • 48 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.